Showing results (11-20 of 171) with videos related to
Sort By:
Pageof 18
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2005
Low-dose granisetron for prophylaxis of acute chemotherapy-induced nausea and vomiting: a pilot studyJanise Moreno, Marina Sahade, Auro del GiglioTumori|November 11, 2003
A phase I study of gemcitabine combined with vinblastine in patients with solid tumorsIzabel Capuchino, Eloah Rabello Suarez, Auro del GiglioRevista Da Associacao Medica Brasileira (1992)|September 20, 2023
The use of artificial intelligence to improve the scientific writing of non-native english speakersAuro Del Giglio, Mateus Uerlei Pereira da CostaJournal of Gastrointestinal Oncology|March 14, 2024
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysisSilvio Matsas, Pedro Nazareth Aguiar, Auro Del GiglioSouthern Medical Journal|March 13, 2009
Increased serum CA-125 levels in patients with lung cancer post thoracotomyGeila Ribeiro Nuñez, Cristina Ito, Auro Del GiglioEinstein (Sao Paulo, Brazil)|April 15, 2026
Utilizing Artificial Intelligence to create narrative literature reviewsAuro Del Giglio, Mateus Uérlei Pereira da CostaAmerican Journal of Clinical Oncology|February 6, 2009
Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trialPaula P Lajolo, Beatriz de Camargo, Auro del GiglioSao Paulo Medical Journal = Revista Paulista De Medicina|April 22, 2008
Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomasVanessa de Carvalho Fabrício, Fernanda Amado, Auro Del GiglioJornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 4, 2020
Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care SystemPedro Aguiar, Felipe Roitberg, Gilberto Lopes, et al.Anti-Cancer Drugs|August 4, 2015
Cumulative meta-analysis of epidermal growth factor receptor-tyrosine kinase inhibitors as first-line therapy in metastatic non-small-cell lung cancerSávia R C Normando, Felipe M Cruz, Auro Del GiglioPageof 18